SAN DIEGO, June 20, 2025--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company today announced the Tandem t:slim X2™ insulin pump with Control ...

Tandem Diabetes Care Announces t:slim X2™ Insulin Pump Compatibility with Abbott’s FreeStyle Libre® 3 Plus Sensor in the United States Tandem continues to build its technology ecosystem to ...

Tandem Diabetes Care, Inc.’s TNDM t:slim X2 insulin pump with Control-IQ+ automated insulin delivery (AID) technology is now compatible with Abbott’s FreeStyle Libre 3 Plus continuous glucose ...

SAN DIEGO, June 20, 2025--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company today announced the Tandem t:slim X2™ insulin pump with Control-IQ+ ...

Tandem Diabetes Care has announced its Tandem t:slim X2 insulin pump is now compatible with Abbott’s FreeStyle Libre 3 Plus ...

t:slim X2, meanwhile, is powered by Control-IQ+ technology. Tandem designed the advanced hybrid closed-loop automated insulin ...

The latest version of Abbott's FreeStyle Libre continuous glucose monitor is now available via the NHS to eligible people with diabetes in the UK. Abbott's wearable FreeStyle Libre 3 device ...

Get instant access to a free live CAC PAB GR Decrement 3.75% streaming chart. The chart is intuitive yet powerful, customize the chart type to view candlestick patterns, area, line graph style ...

33% of S&P 500 trades above 10x price-to-sales, surpassing dot-com levels. We discuss charts that contrast the future profit growth optimism with the reality of economic conditions.

Case in point, equipment suppliers Chart Industries (NYSE: GTLS) and Flowserve Corporation (NYSE: FLS) decided to link up in a "merger of equals," on June 4. Where to invest $1,000 right now?